多个白介素受体基因中的几个单核苷酸多态性(SNP)可能与哮喘风险和/或表型有关。白细胞介素-17(IL-17)与组织炎症和自身免疫性疾病有关。由于以前没有研究揭示IL17受体A(RA)基因变异在哮喘风险中的潜在作用,我们旨在探索四个IL17RASNP的关联(即,rs4819554A/G,rs879577C/T,rs41323645G/A,和rs4819555C/T)在我们地区具有哮喘易感性/表型。TaqMan等位基因判别分析用于192个个体的基因型。我们发现rs4819554G/G基因型显著降低共显性人群的疾病风险(OR=0.15,95CI=0.05-0.45,p<0.001),显性(OR=0.49,95CI=0.26-0.93,p=0.028),和隐性(OR=0.18,95CI=0.07-0.52,p<0.001)模型。同样,rs879577在所有遗传模型中显示与T等位基因相关的疾病风险降低。然而,在所有模型中,rs41323645的A等位基因与疾病风险增加相关.G/A和A/A基因型具有较高的OR值,分别为2.47(95CI=1.19-5.14)和3.86(95CI=1.62-9.18),分别。在显性2.89(95CI=1.47-5.68,p=0.002)和隐性2.34(95CI=1.10-4.98,p=0.025)模型中观察到类似的趋势。对于rs4819555变体,尽管在任何模型下都没有发现显著的关联,rs4819554*A的携带者与哮喘家族史呈阳性(携带者与携带者的比例为71.4%27%的非携带者;p=0.025)和使用缓解剂>2周(52.2%的携带者与28.8%的非携带者;p=0.047)。同时,rs4819555*C携带者在哮喘表型上表现出显著的差异,特别是特应性哮喘(83.3%vs.61.1%;p=0.007),显示胸闷的患病率较高(88.9%vs.61.5%;p=0.029),更有可能报告合并症(57.7%与16.7%,p=0.003)。哮喘组中最常见的单倍型是ACAC,频率为22.87%vs.对照组为1.36%(p<0.001)。总之,所研究的IL17RA变异体在儿童和青少年的哮喘易感性和表型中可能是必需的.
Several single nucleotide polymorphisms (SNPs) in multiple interleukin receptor genes could be associated with asthma risk and/or phenotype. Interleukin-17 (IL-17) has been implicated in tissue inflammation and autoimmune diseases. As no previous studies have uncovered the potential role of IL17 receptor A (RA) gene variants in asthma risk, we aimed to explore the association of four IL17RA SNPs (i.e., rs4819554A/G, rs879577C/T, rs41323645G/A, and rs4819555C/T) with asthma susceptibility/phenotype in our region. TaqMan allelic discrimination analysis was used to genotype 192 individuals. We found that the rs4819554 G/G genotype significantly reduced disease risk in the codominant (OR = 0.15, 95%CI = 0.05-0.45, p < 0.001), dominant (OR = 0.49, 95%CI = 0.26-0.93, p = 0.028), and recessive (OR = 0.18, 95%CI = 0.07-0.52, p < 0.001) models. Similarly, rs879577 showed reduced disease risk associated with the T allele across all genetic models. However, the A allele of rs41323645 was associated with increased disease risk in all models. The G/A and A/A genotypes have higher ORs of 2.47 (95%CI = 1.19-5.14) and 3.86 (95%CI = 1.62-9.18), respectively. Similar trends are observed in the dominant 2.89 (95%CI = 1.47-5.68, p = 0.002) and recessive 2.34 (95%CI = 1.10-4.98, p = 0.025) models. For the rs4819555 variant, although there was no significant association identified under any models, carriers of the rs4819554*A demonstrated an association with a positive family history of asthma (71.4% in carriers vs. 27% in non-carriers; p = 0.025) and the use of relievers for >2 weeks (52.2% of carriers vs. 28.8% of non-carriers; p = 0.047). Meanwhile, the rs4819555*C carriers displayed a significant divergence in the asthma phenotype, specifically atopic asthma (83.3% vs. 61.1%; p = 0.007), showed a higher prevalence of chest tightness (88.9% vs. 61.5%; p = 0.029), and were more likely to report comorbidities (57.7% vs. 16.7%, p = 0.003). The most frequent haplotype in the asthma group was ACAC, with a frequency of 22.87% vs. 1.36% in the controls (p < 0.001). In conclusion, the studied IL17RA variants could be essential in asthma susceptibility and phenotype in children and adolescents.